Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710120 · ClinicalTrials.gov registry record
Hepatitis C Screening Alerts
A clinical trial, sponsored by Epividian.
- Completed
- Registry status
- 125,706
- Enrollment target
NCT05710120 is a clinical trial that has completed, run by Epividian. The registered enrollment target is 125,706 participants.
The verdict
NCT05710120 has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 125,706 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.
Interventions
- OTHER Standard of Care
- OTHER Hepatitis C Screening Alerts in CHORUS™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125,706 participants |
| Start Date | 2023-01-16 |
| Est. Completion | 2023-10-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05710120
The ClinicalTrials.gov registry entry for NCT05710120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125,706 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05710120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05710120 about?
NCT05710120 is a clinical study titled "Hepatitis C Screening Alerts". The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.
What is the current status of trial NCT05710120?
This trial is currently completed. The enrollment target is 125,706 participants. The study started on 2023-01-16. Estimated completion is 2023-10-17.
What interventions are being tested in trial NCT05710120?
The interventions under investigation include: Standard of Care (OTHER), Hepatitis C Screening Alerts in CHORUS™ (OTHER).
Who is sponsoring clinical trial NCT05710120?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.